CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):: US15870P3073
LEI:: 549300O8WKLP8QEG5U47
Country:: United States of America
Address:: 855 N. WOLFE STREET, 21205 BALTIMORE
Website:: https://championsoncology.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Camino Minerals Corporation Advancing high-grade copper and precious metal projects from discovery to production.	Canada	COR
Cantargia Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.	Sweden	CANTA
Captor Therapeutics S.A. Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.	Poland	CTX
Cardiff Oncology, Inc. Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.	United States of America	CRDF
Cardio Diagnostics Holdings, Inc. AI-powered epigenetic and genetic tests for early detection of heart disease risk.	United States of America	CDIO
Cardiol Therapeutics Inc. Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.	United States of America	CRDL
CareDx, Inc. Precision diagnostics and surveillance solutions for the organ transplant journey.	United States of America	CDNA
CAREERLINK CO.,LTD. Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.	Japan	6070
Caris Life Sciences, Inc. Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.	United States of America	CAI
Carna Biosciences, Inc. Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.	Japan	4572